Curt R. Hartman - 15 Sep 2021 Form 4 Insider Report for CONMED Corp (CNMD)

Role
President, CEO and Chair, Director
Signature
/s/ Daniel S. Jonas for Curt R. Hartman by Power of Attorney
Issuer symbol
CNMD
Transactions as of
15 Sep 2021
Transactions value $
-$3,020,233
Form type
4
Filing time
17 Sep 2021, 16:42:19 UTC
Previous filing
04 Jun 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Sale -$318K -2.5K -3.7% $127.39 65K 15 Sep 2021 Direct F1
transaction CNMD Common Stock Options Exercise $1.36M +34K +52.32% $39.87 99K 15 Sep 2021 Direct
transaction CNMD Common Stock Tax liability -$2.46M -19.3K -19.55% $127.24 79.6K 15 Sep 2021 Direct
transaction CNMD Common Stock Options Exercise $1.99M +47.5K +59.65% $41.93 127K 15 Sep 2021 Direct
transaction CNMD Common Stock Tax liability -$3.59M -28.2K -22.17% $127.28 98.9K 15 Sep 2021 Direct
transaction CNMD Common Stock Gift $0 -89K -89.95% $0.00 9.95K 17 Sep 2021 Direct F2
transaction CNMD Common Stock Gift $0 +89K $0.00 89K 17 Sep 2021 Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -34K -100% $0.00* 0 15 Sep 2021 Common Stock 34K $39.87 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -47.5K -29.85% $0.00 112K 15 Sep 2021 Common Stock 47.5K $41.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.
F3 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.